E-drug: TACD on Pharma Registration Data Exclusivity (cont'd)
-------------------------------------------------------------------------
Greg, thanks for this information. When I visited with DGIII in 1998, I
talked with them directly about data exclusivity issue, and they
brought up the issue of patents in Spain and Portugal, and offered that
as the main reason. However, I was not aware that there was a
separate issue regarding biologics, and will add a discussion of this
too.
Jamie
James Love, Consumer Project on Technology
P.O. Box 19367 | http://www.cptech.org
Washington, DC 20036 | love@cptech.org
Voice 202/387-8030 | Fax 202/234-5176
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.